Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis
- PMID: 25369996
- PMCID: PMC4342290
- DOI: 10.1002/art.38933
Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis
Abstract
Objective: The effect of short-term and long-term use of nonsteroidal antiinflammatory drugs (NSAIDs) on structural change is equivocal. The aim of this study was to estimate the extent to which short- and long-term use of prescription NSAIDs relieve symptoms and delay structural progression among patients with radiographically confirmed osteoarthritis (OA) of the knee.
Methods: We applied a new-user design among participants with confirmed OA not reporting NSAID use at the time of enrollment in the Osteoarthritis Initiative. Participants were evaluated for changes in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) subscales (n = 1,846) and joint space width was measured using serial radiographs and a customized software tool (n = 1,116) over 4 years. We used marginal structural modeling to estimate the effect of NSAIDs.
Results: Compared to participants who never reported prescription NSAID use, those reporting use at 1 or 2 assessments had no clinically important changes, but those reporting prescription NSAID use at all 3 assessments had, on average, 0.88 point improvement over the followup period (95% confidence interval [95% CI] -0.46 to 2.22) in pain, 0.72 point improvement (95% CI -0.12 to 1.56) in stiffness, and 4.27 points improvement (95% CI -0.31 to 8.84) in function. The average change in joint space width was 0.28 mm less among those reporting NSAID use at 3 assessments relative to nonusers (95% CI -0.06 to 0.62). Recent NSAID use findings were not clinically or statistically significant.
Conclusion: Long-term, but not short-term, NSAID use was associated with an a priori-defined minimally important clinical change in stiffness, physical function, and joint space width, but not pain. While showing modest clinical importance, the estimates did not reach statistical significance.
Copyright © 2015 by the American College of Rheumatology.
Comment in
-
Editorial: observational studies, time-dependent confounding, and marginal structural models.Arthritis Rheumatol. 2015 Mar;67(3):609-11. doi: 10.1002/art.38931. Arthritis Rheumatol. 2015. PMID: 25371384 No abstract available.
-
Reply: To PMID 25369996.Arthritis Rheumatol. 2015 May;67(8):2278-80. doi: 10.1002/art.39147. Arthritis Rheumatol. 2015. PMID: 25891154 Free PMC article. No abstract available.
-
Is it appropriate to classify all kinds of nonsteroidal antiinflammatory drugs together for assessing the treatment of knee osteoarthritis? Comment on the article by Lapane et al.Arthritis Rheumatol. 2015 May;67(8):2278. doi: 10.1002/art.39150. Arthritis Rheumatol. 2015. PMID: 25891409 No abstract available.
References
-
- Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012;64:465–474. - PubMed
-
- Adatia A, Rainsford KD, Kean WF. Osteoarthritis of the knee and hip. Part II: therapy with ibuprofen and a review of clinical trials. J Pharm Pharmacol. 2012;64:626–36. - PubMed